Britannia sells its UK lab and testing business to a private UK-based acquiror for total enterprise value of up to £24.2 million (CAD$43.6 million) Initial consideration of £18.7 million (CAD$33.7 million) payable in cash on closing Additional...
Read more
Britannia Life Sciences Inc. is pleased to announce the appointment of Mark Bowes-Cavanagh as Chief Executive Officer of its Global Consumer Products Division. In this additional role, Mr. Bowes-Cavanagh will lead the integration and continued...
Read more
Britannia Life Sciences Inc. is pleased to announce the launch of the Green Bridge Gateway, a strategic partnership between its subsidiary, Advanced Development & Safety Laboratories (“ADSL”), the Association for the Cannabinoid Industry...
Read more
Britannia Life Sciences Inc. and its subsidiary, Britannia Mining Solutions Inc. are pleased to provide an update on its mining operations including Paragon Geochemical and the commissioning of BMS’s first PhotonAssayTM unit in Hamilton...
Read more Our company was established to take advantage of positive trends in the Testing, Inspection, and Certification (TIC) industry, with an initial focus on consumer products (cosmetics, food, nutraceuticals). What started out as a cannabis focused...
Read more
Get in touch with our team of professionals and let’s start a conversation.